Tag Archives: Should

Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity

January 16, 2019 Share this content: Obesity is most prevalent in patients with COPD GOLD I and GOLD II stages. In obese patients with chronic obstructive pulmonary disease (COPD), cardiovascular and metabolic comorbidities, particularly hypertension and diabetes, are highly prevalent, and active screening for these disorders should be a priority among healthcare professionals who treat… Read More »